Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-05

Clinical Trial Update: Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

View source ↗

Summary

A real-world study comparing apixaban to vitamin K antagonists for patients with atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)
  • Warfarin (warfarin)

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED